Bandit Arc Research Stack – CJC-1295/Ipamorelin • Tesamorelin • IGF-1 LR3

The Bandit Arc Research Stack from Bandit Research brings together three
popular research peptides—CJC-1295/Ipamorelin, Tesamorelin, and IGF-1 LR3—bundled for
investigators studying the growth hormone (GH) and IGF-1 axis, muscle tissue signaling,
recovery pathways, and body-composition mechanisms in vitro and in preclinical models.
This stack is supplied strictly for laboratory research use only and is not
intended for human or animal use of any kind.

What’s Included in the Bandit Arc Research Stack

• CJC-1295/Ipamorelin (10/10) – A dual-peptide vial combining a GHRH analogue (CJC-1295) with a GH secretagogue (Ipamorelin), commonly used in research on pulsatile growth hormone release and downstream IGF-1 signaling.
• Tesamorelin – A synthetic growth-hormone–releasing hormone (GHRH) analogue studied in preclinical and clinical research for its effects on GH secretion, body-composition pathways, and metabolic signaling.
• IGF-1 LR3 – A long-acting insulin-like growth factor-1 analogue frequently employed in vitro to examine cell growth, differentiation, and anabolic signaling in muscle and other tissues.

Research Focus & Mechanistic Context

This three-peptide stack is designed for advanced laboratories interested in
coordinated modulation of the GH/IGF-1 axis and related cell-signaling networks:

• Growth Hormone Secretion: CJC-1295 and Tesamorelin are both GHRH analogues studied for their ability to stimulate pituitary GH release in preclinical models, while Ipamorelin is a selective secretagogue investigated for its GH-releasing properties with minimal off-target hormone effects.
• IGF-1–Mediated Signaling: IGF-1 LR3 is wid